Cutting edge: flow cytometry in myelodysplastic syndromes

Area of Science:

• Hematology
• Immunology
• Clinical Diagnostics

Background:

• Myelodysplastic syndromes (MDS) diagnosis can be challenging, often requiring multiple methods.
• Flow cytometry (FC) is a valuable tool, particularly when cytomorphology and cytogenetics are inconclusive.

Purpose of the Study:

• To outline standardized minimal requirements for analyzing dysplasia using FC in MDS diagnosis.
• To present tools for implementing FC in the diagnostic workup of MDS.
• To introduce current advances in FC for MDS diagnosis and prognosis.

Main Methods:

• Utilizing proposed minimal requirements from European LeukemiaNet International Workshops for FC standardization in MDS.
• Categorizing FC results into 'normal,' 'suggestive of,' or 'indicative of' MDS.
• Integrating FC as part of a comprehensive diagnostic strategy.

Main Results:

• Standardized FC analysis enables objective categorization of results in cytopenic patients.
• FC provides crucial data when traditional diagnostic methods are equivocal.
• Implementation of FC tools can enhance the diagnostic accuracy for MDS.

Conclusions:

• Flow cytometry is an essential component of an integrated diagnostic approach for myelodysplastic syndromes.
• Standardized FC protocols improve the reliability and interpretability of results.
• Advances in FC offer improved diagnostic and prognostic capabilities for MDS.